RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity

被引:0
作者
Jung, Seong-Mook [1 ]
Kim, Soo Ji [2 ]
Park, Young Chae [1 ]
Seo, Eun Sang [1 ]
Kim, Cheol Gyun [3 ,4 ]
Kim, Taewoo [2 ]
Lee, Sumin [2 ]
Cho, Eunjin [2 ]
Chang, Jun [5 ]
Yun, Cheol-Heui [3 ,4 ]
Shim, Byoung-Shik [2 ]
Cheon, In Su [6 ]
Son, Young Min [1 ]
机构
[1] Chung Ang Univ, Dept Syst Biotechnol, Anseong 17456, South Korea
[2] Int Vaccine Inst, Lab Sci Div, Seoul 08826, South Korea
[3] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea
[4] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea
[5] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea
[6] Mayo Clin, Coll Med & Sci, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
基金
新加坡国家研究基金会;
关键词
respiratory syncytial virus (RSV); vaccination; adjuvant; poly-sorbitol transporter (PST); nanovaccine; systemic humoral immune response; mucosal immunity; SYNCYTIAL VIRUS-INFECTION; CD8(+) T-CELLS; SIZE; SPHINGOSINE-1-PHOSPHATE; IMMUNIZATION; CHALLENGE; PARTICLES;
D O I
10.3390/vaccines12121354
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background/Objectives: Respiratory syncytial virus (RSV) causes symptoms similar to a mild cold for adults, but in case of infants, it causes bronchitis and/or pneumonia, and in some cases, mortality. Mucosal immunity within the respiratory tract includes tissue-resident memory T (TRM) cells and tissue-resident memory B (BRM) cells, which provides rapid and efficient protection against RSV re-infection. Therefore, vaccine strategies should aim to generate mucosal immune responses. However, the interactions between RSV vaccines and mucosal immune responses within the respiratory tract are poorly understood. We evaluated a mucosal immune system following immunization by RSV vaccine with poly-sorbitol transporter (RSV-PST), a nanoparticle adjuvant. Methods: We intranasally immunized the RSV-PST and identified the systemic and mucosal immune responses. Furthermore, we challenged with RSV A2 strain after immunization and investigated the protective effects. Results: Consequently, antigen-specific CD8+ TRM cells were markedly elevated in the lung parenchyma, yet exhibited impaired cytokine expression. In contrast, humoral immunity, with systemic antibody production from serum, but not in the respiratory tract, was significantly increased by RSV-PST immunization. Interestingly, the production of respiratory mucosal antigen-specific IgG after RSV A2 challenge dramatically increased in the bronchoalveolar lavage fluid (BALF) of the RSV-PST immunized group in the presence of FTY720, and the lung-infected RSV titer was significantly lower in this group. Furthermore, after RSV A2 challenge, CD69+ IgG+ BRM cells were significantly increased in lung tissues in the RSV-PST group. Conclusions: The RSV-PST vaccine has protective effects against RSV infection by promoting both systemic and local humoral immunity rather than cellular immunity.
引用
收藏
页数:18
相关论文
共 81 条
  • [1] Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
    Afkhami, Sam
    D'Agostino, Michael R.
    Zhang, Ali
    Stacey, Hannah D.
    Marzok, Art
    Kang, Alisha
    Singh, Ramandeep
    Bavananthasivam, Jegarubee
    Ye, Gluke
    Luo, Xiangqian
    Wang, Fuan
    Ang, Jann C.
    Zganiacz, Anna
    Sankar, Uma
    Kazhdan, Natallia
    Koenig, Joshua F. E.
    Phelps, Allyssa
    Gameiro, Steven F.
    Tang, Shangguo
    Jordana, Manel
    Wan, Yonghong
    Mossman, Karen L.
    Jeyanathan, Mangalakumari
    Gillgrass, Amy
    Medina, Maria Fe C.
    Smaill, Fiona
    Lichty, Brian D.
    Miller, Matthew S.
    Xing, Zhou
    [J]. CELL, 2022, 185 (05) : 896 - +
  • [2] Nanoparticle-Based Vaccines Against Respiratory Viruses
    Al-Halifa, Soultan
    Gauthier, Laurie
    Arpin, Dominic
    Bourgault, Steve
    Archambault, Denis
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [3] The establishment of resident memory B cells in the lung requires local antigen encounter
    Allie, S. Rameeza
    Bradley, John E.
    Mudunuru, Uma
    Schultz, Michael D.
    Graf, Beth A.
    Lund, Frances E.
    Randall, Troy D.
    [J]. NATURE IMMUNOLOGY, 2019, 20 (01) : 97 - +
  • [4] Intravascular staining for discrimination of vascular and tissue leukocytes
    Anderson, Kristin G.
    Mayer-Barber, Katrin
    Sung, Heungsup
    Beura, Lalit
    James, Britnie R.
    Taylor, Justin J.
    Qunaj, Lindor
    Griffith, Thomas S.
    Vezys, Vaiva
    Barber, Daniel L.
    Masopust, David
    [J]. NATURE PROTOCOLS, 2014, 9 (01) : 209 - 222
  • [5] Genetic and Epigenetic Regulation of PD-1 Expression
    Bally, Alexander P. R.
    Austin, James W.
    Boss, Jeremy M.
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196 (06) : 2431 - 2437
  • [6] Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
    Bian, Lijun
    Zheng, Yu
    Guo, Xiaohong
    Li, Dongdong
    Zhou, Jingying
    Jing, Linyao
    Chen, Yan
    Lu, Jingcai
    Zhang, Ke
    Jiang, Chunlai
    Zhang, Yong
    Kong, Wei
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes
    Blank, Fabian
    Stumbles, Philip A.
    Seydoux, Emilie
    Holt, Patrick G.
    Fink, Alke
    Rothen-Rutishauser, Barbara
    Strickland, Deborah H.
    von Garnier, Christophe
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2013, 49 (01) : 67 - 77
  • [8] Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
    Caidi, Hayat
    Miao, Congrong
    Thornburg, Natalie J.
    Tripp, Ralph A.
    Anderson, Larry J.
    Haynes, Lia M.
    [J]. ANTIVIRAL RESEARCH, 2018, 154 : 149 - 157
  • [9] Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases
    Carbone, Francis R.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2023, 23 (05) : 329 - 335
  • [10] Visualization and characterization of respiratory syncytial virus F-specific CD8+ T cells during experimental virus infection
    Chang, J
    Srikiatkhachorn, A
    Braciale, TJ
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (08) : 4254 - 4260